| SCHEDULE OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH |
Cash,
cash equivalents, and restricted stock consisted of the following:
SCHEDULE
OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
| |
|
March 31, 2021 |
|
|
December 31, 2020 |
|
| Cash |
|
$ |
3,384,067 |
|
|
$ |
1,238,611 |
|
| Money market fund |
|
|
63,229,179 |
|
|
|
84,194,830 |
|
| Cash and cash equivalents |
|
|
66,613,246 |
|
|
$ |
85,433,441 |
|
| |
|
|
|
|
|
|
|
|
| Restricted cash, current |
|
|
350,000 |
|
|
|
350,000 |
|
| Restricted cash, noncurrent |
|
|
669,900 |
|
|
|
669,900 |
|
| Restricted cash |
|
|
1,019,900 |
|
|
|
1,019,900 |
|
| Total cash, cash equivalents, and restricted cash shown in the statement of cash flows |
|
$ |
67,633,146 |
|
|
$ |
86,453,341 |
|
|
| SCHEDULE OF COMPUTATION OF NET LOSS PER COMMON SHARE |
Net
loss per share was computed as follows:
SCHEDULE OF COMPUTATION OF NET LOSS PER COMMON SHARE
| |
|
Three Months Ended March
31
|
|
| |
|
2021 |
|
|
2020 |
|
| |
|
|
|
|
|
|
| Net loss |
|
$ |
(16,065,168 |
) |
|
$ |
(29,656,800 |
) |
| Weighted average number of common shares-basic and diluted* |
|
|
116,344,900 |
|
|
|
69,272,402 |
|
| Net loss per share of common stock-basic
and diluted* |
|
$ |
(0.14 |
) |
|
$ |
(0.43 |
) |
| |
* |
Warrants
and options that have not been exercised have been excluded from the diluted calculation as all periods presented have a net loss and
the impact of these securities would be anti-dilutive |
|